Lumosa Therapeutics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	174.52	235.49	425.25	516.85	840.32	898.64
Short-Term Investments	665.96	1,117	419.06	667.67	589.89	372.26
Trading Asset Securities	-	-	-	-	21.89	-
Cash & Short-Term Investments	840.48	1,353	844.31	1,185	1,452	1,271
Cash Growth	51.27%	60.23%	-28.72%	-18.43%	14.26%	103.34%
Accounts Receivable	11.27	20.63	12	14	9.69	13.84
Other Receivables	13.62	19.16	18.13	17.98	17.01	16.38
Receivables	24.89	39.79	30.14	31.98	26.7	30.22
Inventory	95.22	97.78	103.91	108.68	82.39	31.78
Prepaid Expenses	55.07	46.64	65.66	60.88	59.17	13.65
Other Current Assets	0.02	0.02	0.02	-	0.13	0.02
Total Current Assets	1,016	1,537	1,044	1,386	1,620	1,347
Property, Plant & Equipment	17.17	19.68	27.53	7.66	13	19.5
Long-Term Investments	699.06	575.42	583.79	464.72	671.32	246.72
Goodwill	-	-	-	-	-	78.49
Other Intangible Assets	0.4	0.49	0.6	26.93	43.57	92.72
Other Long-Term Assets	0.32	0.32	0.32	0.32	0.32	0.32
Total Assets	1,733	2,133	1,656	1,886	2,349	1,784
Accounts Payable	0.03	1.42	1.49	12.25	14.5	0.03
Accrued Expenses	35.79	36.7	54.41	33.62	43.26	28.68
Current Portion of Leases	6.89	4.2	4.49	4.33	5.4	5.83
Current Unearned Revenue	2.8	3.04	3.04	6.88	4.68	0.32
Other Current Liabilities	82.83	155.83	156.14	158.28	156.18	155.65
Total Current Liabilities	128.34	201.18	219.58	215.36	224.03	190.5
Long-Term Leases	1.74	4.28	8.12	0.36	6.08	11.13
Total Liabilities	130.09	205.46	227.69	215.72	230.11	201.63
Common Stock	1,688	1,689	1,650	1,631	1,632	1,474
Additional Paid-In Capital	300.28	2,223	1,363	1,268	1,271	963.36
Retained Earnings	-284.91	-1,919	-1,494	-1,256	-761.44	-857.38
Comprehensive Income & Other	-55.32	-81.59	-117.45	-13.53	-22.98	2.96
Total Common Equity	1,591	1,912	1,401	1,630	2,119	1,583
Minority Interest	11.13	15.84	27.89	40.18	-	-
Shareholders' Equity	1,603	1,928	1,429	1,670	2,119	1,583
Total Liabilities & Equity	1,733	2,133	1,656	1,886	2,349	1,784
Total Debt	8.63	8.48	12.61	4.69	11.49	16.95
Net Cash (Debt)	831.85	1,344	831.7	1,180	1,441	1,254
Net Cash Growth	52.32%	61.64%	-29.51%	-18.10%	14.89%	104.46%
Net Cash Per Share	5.00	8.22	5.12	7.26	9.55	10.38
Filing Date Shares Outstanding	168.46	168.9	164.97	163.1	163.15	147.37
Total Common Shares Outstanding	168.46	168.9	164.97	163.1	163.15	147.37
Working Capital	887.34	1,336	824.46	1,171	1,396	1,156
Book Value Per Share	9.45	11.32	8.49	9.99	12.99	10.74
Tangible Book Value	1,591	1,911	1,400	1,603	2,075	1,411
Tangible Book Value Per Share	9.44	11.32	8.49	9.83	12.72	9.58
Machinery	42.44	41.95	41.5	31.82	29.53	29.53
Leasehold Improvements	3.21	3.21	3.21	-	-	0.24

Source: S&P Global Market Intelligence. Standard template. Financial Sources.